Sight Diagnostics

Sight Diagnostics
Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.
About
What does Sight Diagnostics do?
Sight Diagnostics aims to improve health outcomes through fast, accurate, and convenient diagnostic testing. Their flagship product, Sight OLO, is a compact analyzer that performs a Complete Blood Count (CBC), the most commonly ordered blood test, in minutes, providing critical information for timely treatment decisions.
What is Sight Diagnostics's revenue?
StartupHub estimates Sight Diagnostics's annual revenue at $12.0M (range $6.6M to $22.8M, 66% confidence), based on comparable companies in the sector.
What is Sight Diagnostics's valuation?
StartupHub estimates Sight Diagnostics's effective valuation at $266.3M (range $186.4M to $346.1M, 27% confidence), based on comparable companies in the sector.
How much funding has Sight Diagnostics raised?
Sight Diagnostics has raised a total of $124M in funding. The most recent round on record is Series D.
Where is Sight Diagnostics headquartered?
Sight Diagnostics is headquartered in Tel Aviv, Israel.
When was Sight Diagnostics founded?
Sight Diagnostics was founded in 2011.
What industry does Sight Diagnostics operate in?
Sight Diagnostics operates in Healthcare, Diagnostics, Blood, MedTech, HealthTech, Blood Diagnostics.
How many employees does Sight Diagnostics have?
Sight Diagnostics has approximately 65 people on record.
“Sight Diagnostics on brink of closure after laying off all employees.”
View on Reddit“I heard of a company trying to do what Holmes and Theranos did (before they turned bad), called Sight Diagnostics, from Tel Aviv (I think), and some other companies like Vital Biosciences (SF, backed by Sam Altman of OpenAI) and Babson Diag…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
